You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Mineralocorticoid receptor modulator

Showing 1 - 25 of 7,659
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Renin Angiotensin Aldosterone System Genetic Polymorphism on

Recruiting
  • Myocardial Infarction
    • Cairo, Egypt
      Ain Shams University
    May 16, 2023

    Primary Aldosteronism Trial in Montréal (Renin measurements)

    Not yet recruiting
    • Primary Aldosteronism
    • Renin measurements
    • Montréal, Quebec, Canada
      Hôpital du Sacré-Coeur de Montréal
    Oct 30, 2023

    Heart Failure Trial (Finerenone, Placebo)

    Not yet recruiting
    • Heart Failure
    • (no location specified)
    Sep 11, 2023

    Chronic Kidney Disease, Albuminuria Trial in Birmingham (Spironolactone, Amiloride)

    Completed
    Has Results
    • Chronic Kidney Disease
    • Albuminuria
    • Birmingham, Alabama
      Hypertension Research Clinic at UAB
    Nov 21, 2022

    Atherosclerosis Trial in Cleveland (Spironolactone, Placebo)

    Completed
    • Atherosclerosis
    • Cleveland, Ohio
      University Hospitals Cleveland Medical Center
    Sep 16, 2022

    s to Learn More About Treatment With Steroidal Mineralocorticoid

    Active, not recruiting
    • Chronic Kidney Disease
    • +2 more
    • sMRA therapies
    • Whippany, New Jersey
      Many Locations
    Jan 30, 2023

    Primary Hyperaldosteronism Due to Adrenal Adenoma Trial in Gothenburg, Stockholm, Umeå (Unilateral adrenalectomy, Medical

    Not yet recruiting
    • Primary Hyperaldosteronism Due to Adrenal Adenoma
    • Unilateral adrenalectomy
    • Medical treatment (eplerenone)
    • Gothenburg, Sweden
    • +2 more
    Mar 30, 2023

    Hypertension, Left Ventricular Hypertrophy Trial (Eplerenone, Chlorthalidone, Potassium)

    Not yet recruiting
    • Hypertension
    • Left Ventricular Hypertrophy
    • (no location specified)
    Oct 26, 2022

    Primary Aldosteronism, Hypertension Trial (Finerenone, Spironolactone)

    Not yet recruiting
    • Primary Aldosteronism
    • Hypertension
    • (no location specified)
    Apr 3, 2023

    Metabolic Syndrome, Hypertension, Overweight and Obesity Trial in Boston (Eplerenone, Chlorthalidone with potassium chloride)

    Recruiting
    • Metabolic Syndrome
    • +2 more
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Feb 28, 2022

    Hypertension Trial in Ann Arbor (Placebo, Eplerenone 50mg)

    Not yet recruiting
    • Hypertension
    • Placebo
    • Eplerenone 50mg
    • Ann Arbor, Michigan
      University of Michigan
    Feb 4, 2022

    Heart Failure With Reduced Ejection Fraction Trial in New Haven (Best Practice Alert)

    Recruiting
    • Heart Failure With Reduced Ejection Fraction
    • Best Practice Alert
    • New Haven, Connecticut
      Cardiology/Internal Medicine Outpatient Clinics of Yale New Heal
    Jan 17, 2022

    Kidney Transplantation for More Than One Year, Patients With a Kidney Transplantation on Cyclosporine Trial in

    Recruiting
    • Kidney Transplantation for More Than One Year
    • Patients With a Kidney Transplantation on Cyclosporine
    • Eplerenone 50mg/day (cross over design)
    • Period without eplerenone (cross over design)
    • Vandœuvre-lès-Nancy, France
      CHRU de Nancy
    Aug 17, 2022

    Chronic Kidney Diseases Trial (Mineralocorticoid receptor antagonist, Placebo)

    Not yet recruiting
    • Chronic Kidney Diseases
    • Mineralocorticoid receptor antagonist
    • Placebo
    • (no location specified)
    Sep 21, 2023

    Leiomyoma Trial run by the NICHD (ulipristal acetate 20 mg, ulipristal acetate 10 mg, )

    Completed
    Has Results
    • Leiomyoma
    • ulipristal acetate 20 mg
    • +2 more
    • Bethesda, Maryland
    • +1 more
    Feb 14, 2022

    Prostate Cancer Trial in Gainesville, Baltimore, Boston (LY2452473, Placebo)

    Completed
    Has Results
    • Prostate Cancer
    • Gainesville, Florida
    • +3 more
    Sep 27, 2021

    Heart Failure Trial in Worldwide (Spironolacton)

    Completed
    • Heart Failure
    • Corbeil-Essonnes, France
    • +8 more
    Mar 7, 2022

    COVID-19 Pneumonia Trial in Szczecin (Canrenoate Potassium, Normal Saline)

    Recruiting
    • COVID-19 Pneumonia
    • Canrenoate Potassium
    • Normal Saline
    • Szczecin, Poland
      Pomeranian Medical University
    Jun 3, 2021

    HIV Trial in Boston (Eplerenone, Placebo, Lifestyle Modification)

    Completed
    • HIV
    • Boston, Massachusetts
      Massachusetts General Hospital
    Jul 14, 2022

    Heart Failure, Hyperkalemia Trial in Gothenburg (Sodium zirconium cyclosilicate, Placebo)

    Recruiting
    • Heart Failure
    • Hyperkalemia
    • Sodium zirconium cyclosilicate
    • Placebo
    • Gothenburg, Sweden
      Sahlgrenska University Hospital-Ostra Hospital
    Sep 20, 2021

    Women With Mutations in the Breast Cancer Susceptibility Genes BRCA1,2 Trial in Stockholm (Mifepristone)

    Completed
    • Women With Mutations in the Breast Cancer Susceptibility Genes BRCA1,2
    • Stockholm, Sweden
      Department of Woman and Child Health Karolinska University Hospi
    Jan 15, 2022

    Androgen Receptor Positive, Estrogen Receptor Negative, HER2/Neu Negative Trial in United States (drug, other, biological)

    Active, not recruiting
    Has Results
    • Androgen Receptor Positive
    • +5 more
    • Corona, California
    • +6 more
    Jun 8, 2022

    Hepatitis B, Chronic Trial in Hong Kong, Korea, Republic of, Taiwan (EYP001a, Entecavir, Pegylated interferon alpha2a)

    Active, not recruiting
    • Hepatitis B, Chronic
    • Hong Kong, Hong Kong
    • +5 more
    Sep 27, 2021

    Primary Aldosteronism, Hypertension Trial (Eplerenone)

    Not yet recruiting
    • Primary Aldosteronism
    • Hypertension
    • (no location specified)
    Aug 26, 2021

    Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer Trial in Miami (AI+CDK4/6i, SERD+CDK4/6i, mTOR inhibitor +

    Not yet recruiting
    • Breast Cancer
    • +3 more
    • Miami, Florida
      University of Miami
    Apr 12, 2023